Tuesday was another exciting day in the Massachusetts Pavilion!
11 a.m. Special announcement from Senate President Therese Murray
Our first announcement of the day was from Senate President Therese Murray. She unveiled a new multinational research collaboration around throat cancer – a partnership involving the United States, Northern Ireland, the Catalonia region of Spain, and Finland. She also announced that a US-EU Conference will be in Boston October 23-24 and will focus on promoting electronic health collaboration. This will be the first US-EU Conference held outside Washington D.C.
2:45 p.m. Translating Regenerative Medicine Therapy into the Clinic
At 2:45, thought leaders in Regenerative Medicine Therapy joined us to discuss the cell-based therapies, stem cells, and the future of the field of regenerative medicine.
Life sciences company BG Medicine Inc. has received $15 million in capital to finance its commercialization efforts. Link
2. 4s3 receives $20M Series A round Mass High Tech – 3/5/12
4s3 Bioscience, Inc., a privately-held Medford company that develops genetic disease therapies for orphan neuromuscular disorders, has closed on a $20 million round of Series A financing with KLP Enterprises, LLP, according to a release from 4s3. Link
3. New state coalition forms to promote biopharma industry Boston Herald – 3/7/12
The coalition, We Work For Health, includes more than a dozen organizations from the Bay State’s academic, business, labor, health care and biotech sectors, as well as community-based groups, including the South Shore Chamber of Commerce, the Massachusetts Association for Mental Health and the Massachusetts Biotechnology Council. Link